Market Place
Sourcing Support
All News #Library
Biotech
Lundbeck Unveils AAN 2026 Data Showing VYEPTI Impact On Migraine
19 Apr 2026 //
PR NEWSWIRE
Lundbeck Presents New Neurology Data At AAN Annual Meeting
13 Apr 2026 //
PR NEWSWIRE
Lundbeck Progresses Parkinson`s Research With New Phase 1B Data
17 Mar 2026 //
PHARMIWEB
Lundbeck Reports Positive Ph2B Results For Bocunebart in Migraine
12 Feb 2026 //
PHARMIWEB
Lundbeck Files for Marketing Authorization Across for Vyepti
14 Nov 2025 //
PR NEWSWIRE
Lundbeck, OpenAI Partner To Drive Innovation, Boost Productivity
28 Oct 2025 //
PHARMIWEB
Lundbeck, Contera Pharma Partner To Advance RNA Targeting Drugs
21 Oct 2025 //
PHARMIWEB
Lundbeck Shows Vyepti Long-Term Migraine Prevention Efficacy
11 Sep 2025 //
PR NEWSWIRE
Lundbeck blames DTC blackout for slowdown in Rexulti growth
16 May 2024 //
FIERCE PHARMA
Lundbeck to Present New Clinical and Real-World VYEPTI® (eptinezumab-jjmr) Data
15 Jun 2023 //
BUSINESSWIRE
Lundbeck out-licenses three candidates to Cambridge biotech
08 May 2023 //
ENDPTS
Alloy to Empower Drug Discovery of Lundbeck’s Biologics for Brain Health
02 May 2023 //
BUSINESSWIRE
FDA accepts one, delays another; Data, deals and dollars for slate of biotechs
09 Jan 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.